▲ Peaking
Business
🔮 fades
A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High
Amylyx Pharmaceuticals shares surge to a three-year high following a successful Phase 3 trial for Avexitide, a GLP-1 antagonist.